Q4 2016 Holdings
Filed 2017-02-13 | 143 holdings | $260.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Retrophin, Inc. | Common | 761299106 | $3.2K | 167,949 | 0.0% |
| Allergan plc | Preferred Convertible | G0177J116 | $3.8K | 5,000 | 0.0% |
| Immunomedics, Inc. | Note 4.75% 2/15/20 | 452907AK4 | $4.0K | $4,000,000 | 0.0% |
| Momenta Pharmaceuticals, Inc.(MNTA) | Common | 60877T100 | $4.6K | 306,600 | 0.0% |
| Karyopharm Therapeutics Inc.(KPTIEUR) | Common | 48576U106 | $4.7K | 500,324 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $4.8K | 400,000 | 0.0% |
| Myovant Sciences Ltd. | Common | G637AM102 | $5.0K | 400,000 | 0.0% |
| Dermira, Inc.(DERMEUR) | Common | 24983L104 | $5.0K | 165,200 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $5.4K | 700,000 | 0.0% |
| Icon plc(ICLR) | Shares | G4705A100 | $5.4K | 72,000 | 0.0% |
| Global Blood Therapeutics, Inc. | Common | 37890U108 | $5.5K | 381,300 | 0.0% |
| New Senior Investment Group Inc. | Common | 648691103 | $5.6K | 567,997 | 0.0% |
| PRA Health Sciences, Inc.(PRAH) | Common | 69354M108 | $5.6K | 102,000 | 0.0% |
| Pieris Pharmaceuticals, Inc. | Common | 720795103 | $5.8K | 4,145,958 | 0.0% |
| Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | $6.1K | $7,000,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common | 90400D108 | $6.2K | 88,400 | 0.0% |
| LTC Properties, Inc.(LTC) | Common | 502175102 | $6.4K | 136,212 | 0.0% |
| Flamel Technologies SA | Sponsored ADR | 338488109 | $6.5K | 624,288 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $7.2K | 327,735 | 0.0% |
| Galapagos NV(GLPG) | Sponsored ADR | 36315X101 | $7.4K | 115,738 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $8.0K | 260,200 | 0.0% |
| Exelixis, Inc.(EXEL) | Common | 30161Q104 | $8.2K | 551,647 | 0.0% |
| Care Capital Properties, Inc. | Common | 141624106 | $8.6K | 345,022 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | Note 2.00% 5/15/19 | 00767EAB8 | $9.3K | $13,000,000 | 0.0% |
| Physicians Realty Trust(DOCUSD) | Common | 71943U104 | $10.1K | 530,672 | 0.0% |
| Merus B.V. | Common | N5749R100 | $10.1K | 479,150 | 0.0% |
| Foamix Pharmaceuticals Ltd | Shares | M46135105 | $10.3K | 930,398 | 0.0% |
| Natera, Inc.(NTRA) | Common | 632307104 | $10.3K | 882,358 | 0.0% |
| Becton, Dickinson and Co.(BDX) | Common | 075887109 | $10.4K | 63,078 | 0.0% |
| Zimmer Biomet Holdings, Inc.(ZBH) | Common | 98956P102 | $10.6K | 102,300 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $10.6K | 179,000 | 0.0% |
| Cardinal Health, Inc.(CAH) | Common | 14149Y108 | $11.0K | 152,500 | 0.0% |
| Ventas, Inc.(VTR) | Common | 92276F100 | $11.0K | 175,991 | 0.0% |
| Cigna Corporation | Common | 125509109 | $11.5K | 86,400 | 0.0% |
| Paratek Pharmaceuticals, Inc. | Common | 699374302 | $11.7K | 762,581 | 0.0% |
| Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | $12.0K | 200,000 | 0.0% |
| Senior Housing Properties Trust | Shares | 81721M109 | $12.2K | 646,554 | 0.0% |
| Sanofi(SNY) | Sponsored ADR | 80105N105 | $12.3K | 305,000 | 0.0% |
| Medical Properties Trust, Inc.(MPT) | Common | 58463J304 | $12.4K | 1,007,717 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $12.7K | 463,800 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $12.8K | 466,300 | 0.0% |
| United Therapeutics Corporation(UTHR) | Common | 91307C102 | $13.4K | 93,100 | 0.0% |
| Sabra Health Care REIT, Inc.(SBRA) | Common | 78573L106 | $13.5K | 550,990 | 0.0% |
| GlaxoSmithKline plc | Sponsored ADR | 37733W105 | $13.8K | 359,000 | 0.0% |
| HCA Holdings, Inc.(HCA) | Common | 40412C101 | $14.1K | 190,232 | 0.0% |
| Omega Healthcare Investors, Inc.(OHI) | Common | 681936100 | $14.3K | 458,616 | 0.0% |
| Endo International plc | Shares | G30401106 | $15.1K | 914,548 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $15.2K | 391,869 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $15.3K | 57,670 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $15.5K | 132,352 | 0.0% |